63 Épisodes

  1. ASO Series: Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody

    Publié: 10/12/2024

  2. ASO Series: A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer

    Publié: 19/11/2024

  3. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database

    Publié: 08/10/2024

  4. SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods

    Publié: 10/09/2024

  5. Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages

    Publié: 13/08/2024

  6. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies

    Publié: 16/07/2024

  7. Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network

    Publié: 11/06/2024

  8. The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women

    Publié: 21/05/2024

  9. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6

    Publié: 09/04/2024

  10. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer

    Publié: 12/03/2024

  11. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?

    Publié: 13/02/2024

  12. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study

    Publié: 09/01/2024

  13. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer

    Publié: 12/12/2023

  14. Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients

    Publié: 14/11/2023

  15. Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects

    Publié: 10/10/2023

  16. Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer

    Publié: 12/09/2023

  17. Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

    Publié: 08/08/2023

  18. Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT

    Publié: 11/07/2023

  19. A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases

    Publié: 13/06/2023

  20. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

    Publié: 09/05/2023

1 / 4

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Visit the podcast's native language site